NEUROCONTROL FREEHAND SYSTEM(R)

Stimulator, Neuromuscular, Implanted

FDA Premarket Approval P950035

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the freehand system(r). The system includes: implantable receiver-stimulator model 202-1, implantable epimysial electrode set model 203-1, surgical electrode positioning kit model 207-1, patient external system model 204-1, programming system model 209-1. The system is an upper extremity neuroprosthesis and is intended to improve a patient's ability to grasp, hold, and release objects. The system is indicated for use in patients who: are tetraplegic due to c5 or c6 spinal cord injury (asia classification); have adequate functional range of motion of the upper extremity; have intact lower motor neuron innervation of hte forearm and hand musculature; and are skeletally mature.

DeviceNEUROCONTROL FREEHAND SYSTEM(R)
Classification NameStimulator, Neuromuscular, Implanted
Generic NameStimulator, Neuromuscular, Implanted
ApplicantBIOCONTROL TECHNOLOGY, INC.
Date Received1995-10-31
Decision Date1997-08-15
Notice Date1997-11-14
PMAP950035
SupplementS
Product CodeGZC
Docket Number97M-0458
Advisory CommitteePhysical Medicine
Expedited ReviewNo
Combination Product No
Applicant Address BIOCONTROL TECHNOLOGY, INC. 1945 East 97th cleveland, OH 44106-4720

Supplemental Filings

Supplement NumberDateSupplement Type
P950035Original Filing
S010 2001-08-14 Special (immediate Track)
S009 2000-12-22 Normal 180 Day Track
S008 2000-07-11 Normal 180 Day Track
S007 2000-03-14 Real-time Process
S006 2000-02-29 Normal 180 Day Track
S005 1999-11-24 Real-time Process
S004 1999-04-07 Normal 180 Day Track
S003 1998-12-02 Normal 180 Day Track
S002 1998-06-29 Special (immediate Track)
S001 1998-02-10 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.